SCHEMBL9720

SCHEMBL9720

C#CCCCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15124812 0.92 — —
SCHEMBL27988568 0.90 CYP1A2 (0.67) —
SCHEMBL30836939 0.90 CYP1A2 (0.67) —
SCHEMBL4235132 0.90 CYP1A2 (0.67) —
SCHEMBL15124720 0.90 CYP1A2 (0.67) —
SCHEMBL4231630 0.90 CYP1A2 (0.67) —
SCHEMBL233701 0.86 — —
SCHEMBL27809378 0.80 CYP1A2 (0.54) —
SCHEMBL1308391 0.78 — —
SCHEMBL9086 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2491037-A1 COMPOUNDS Respivert Limited (GB) 2012-08-29 — — EP claimed
WO-2011048111-A1 COMPOUNDS RESPIVERT LIMITED (GB) 2011-04-28 — — WO claimed
US-20250223280-A1 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2025-07-10 — — US disclosed
US-12312340-B2 Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins AVILAR THERAPEUTICS, INC. (US) 2025-05-27 — — US disclosed
CN-120035588-A Aromatic acetylene derivative, preparation method and medical application thereof 浙江海正药业股份有限公司 2025-05-23 — — CN disclosed
CN-119306732-B Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-04-25 — — CN disclosed
US-20250129118-A1 MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE H LEE MOFFITT CANCER CT & RES (US) 2025-04-24 — — US disclosed
CN-113683622-B Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-02-18 — — CN disclosed
CN-119306732-A Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-01-14 — — CN disclosed
CN-119241554-A Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2025-01-03 — — CN disclosed
CN-119219654-A Bioactive substance conjugate, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-12-31 — — CN disclosed
EP-1157019-A1 4-ALKENYL (AND ALKYNYL) OXINDOLES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES, IN PARTICULAR CDK2 F. HOFFMANN-LA ROCHE AG (CH) 2001-11-28 — — EP disclosed
US-6303793-B1 INTERMEDIATES FOR CYCLIN-DEPENDENT KINASE INHIBITORS HOFFMANN-LA ROCHE INC. 2001-10-16 — — US disclosed
US-6252086-B1 CYCLIN-DEPENDENT KINASES INHIBITORS; ANTICANCER AGENTS HOFFMANN-LA ROCHE INC. 2001-06-26 — — US disclosed
EP-0765879-B1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO CO (JP) 2001-02-14 — — EP disclosed
US-6130239-A INHIBIT CYCLIN-DEPENDENT KINASES HOFFMANN-LA ROCHE INC. (US) 2000-10-10 — — US disclosed
WO-2000035908-A1 4-ALKENYL (AND ALKYNYL) OXINDOLES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES, IN PARTICULAR CDK2 F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 — — WO disclosed
US-5861429-A MITICIDES AND ANTHELMINTICS SANKYO COMPANY, LIMITED (JP) 1999-01-19 — — US disclosed
EP-0765879-A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO COMPANY LIMITED (JP) 1997-04-02 — — EP disclosed
EP-0361772-A2 Cyclopentyl ethers and their preparation and pharmaceutical formulation GLAXO GROUP LIMITED (GB) 1990-04-04 — — EP disclosed
Send feedback